Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 8
Author(s): Peter J. Atkinson
Affiliation:
Export Options
About this article
Cite this article as:
Atkinson J. Peter , Meet Our Editorial Board Member, Current Neuropharmacology 2017; 15 (8) . https://dx.doi.org/10.2174/1570159X1508171114112636
DOI https://dx.doi.org/10.2174/1570159X1508171114112636 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
16
3
2
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Treatment Options Using 5-HT3 Receptor Antagonists in Rheumatic Diseases
Current Topics in Medicinal Chemistry Why are Antidepressant Drugs Effective Smoking Cessation Aids?
Current Neuropharmacology Neuroendocrine Stimulation of Mucosal Immune Cells in Inflammatory Bowel Disease
Current Pharmaceutical Design Schizophrenia and Idiopathic Unconjugated Hyperbilirubinemia (Gilberts Syndrome)
Central Nervous System Agents in Medicinal Chemistry Exploring N<sup>1</sup>-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
CNS & Neurological Disorders - Drug Targets Is Targeting microRNAs the Philosopher’s Stone for Vascular Disease?
Current Vascular Pharmacology Melatonin Decreases Levels of S100β and NFκB, Increases Levels of Synaptophysinina Rat Model of Alzheimer's Disease
Current Aging Science Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder
Current Neuropharmacology Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease
Current Alzheimer Research Anti-Cytokine Therapeutics: History and Update
Current Pharmaceutical Design Blurred Edges: Evolving Concepts of Autism Spectrum Disorders and Schizophrenia
Adolescent Psychiatry It is All About Proteases: From Drug Delivery to In Vivo Imaging and Photomedicine
Current Medicinal Chemistry Treatment Approaches in Elderly Patients with Head and Neck Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial: Sleeplessness, Loneliness and Stigma: Under-recognized Problems in Adolescent Psychiatry
Adolescent Psychiatry The Epidemiology and Health Effects of Tobacco Smoke Exposure
Current Pediatric Reviews Marine Food Protection in Testicular Damages Caused by Diabetes Mellitus
Current Diabetes Reviews Angina in Women without Obstructive Coronary Artery Disease
Current Cardiology Reviews Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies
Recent Patents on Nanotechnology Preface
Current Psychopharmacology Formulation and Optimization of Ethosomes for Transdermal Delivery of Ropinirole Hydrochloride
Current Drug Delivery